CliffBio
small molecule

COMBIPATCH

ESTRADIOL; NORETHINDRONE ACETATE

Loss of exclusivity—loss of exclusivity
CompanyNoven Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCOMBIPATCH
Active ingredientESTRADIOL; NORETHINDRONE ACETATE
Strength0.05MG/24HR;0.14MG/24HR
Dosage formFILM, EXTENDED RELEASE
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalAugust 1998
Marketing statusRX

More from Noven Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.